How Can Aesthetic Clinics Structure A Combination Protocol Using Nd:yag Lasers And Ipl For Facial Telangiectasia And Erythema? A Staged Approach

A staged combination protocol is generally the most logical approach when facial telangiectasia coexists with diffuse erythema. Begin with a long-pulsed 1064 nm Nd:YAG laser to treat larger, discrete, and deeper vessels, then allow approximately 30 days for recovery before using IPL to reduce broad background redness and residual superficial capillary networks. The IPL phase commonly involves two sessions spaced about 40 days apart, with treatment parameters adjusted to the patient, vessel characteristics, skin type, and device.

Use the Nd:YAG laser for depth and focal vessel coagulation; use IPL for breadth and superficial diffuse redness. Staging the modalities allows each system to address the vascular component it is best suited to treating while limiting unnecessary thermal overlap.

Why the Two Modalities Complement Each Other

Nd:YAG targets deeper discrete vessels

The 1064 nm wavelength penetrates more deeply into the dermis than IPL and is useful for larger, deeper, or more sharply defined telangiectasias. Its focused spot size also allows the clinician to treat visible vessels selectively rather than exposing the entire facial surface to high vascular fluence.

Selective photothermolysis occurs when vascular chromophores absorb sufficient energy to produce controlled vessel coagulation while the surrounding tissue and epidermis are protected. The clinical endpoint should be assessed conservatively because excessive heating increases the risk of burns, prolonged inflammation, and pigmentary change.

IPL treats the broader vascular field

IPL delivers a broad spectrum of light and can cover larger areas efficiently. It is therefore better suited to diffuse background erythema, flushing, and fine superficial capillary networks that are too widespread for focal Nd:YAG treatment.

A vascular filter, such as a 500 nm filter, can be selected when the treatment objective is superficial vascular redness. Filter choice, pulse structure, and fluence remain device-specific and must be matched to the patient’s skin and vascular response.

A Practical Staged Protocol

Stage 1: Map and treat focal telangiectasia with Nd:YAG

The first stage should focus on discrete vessels that are visually identifiable, relatively larger, or suspected to extend deeper into the dermis.

The primary reference describes a 1064 nm Nd:YAG protocol using:

Fluence: approximately 75–100 J/cm²
Spot size: 5 mm
Pulse structure: double pulse
Pulse duration: approximately 5–14 ms
Inter-pulse interval: 20 ms
Protection: surface cooling

These values should be treated as a clinical reference range, not a universal prescription. Actual settings depend on the specific platform, cooling system, skin phototype, vessel diameter, vessel depth, treatment site, and the observed clinical endpoint.

Stage 2: Allow a recovery interval

A recovery period of approximately 30 days separates the Nd:YAG treatment from the IPL phase in the reference protocol.

This interval allows acute erythema, edema, crusting, or other treatment effects to settle and gives the clinician an opportunity to reassess which vessels and areas of diffuse redness remain. The next treatment should be postponed if the skin has not returned to an acceptable baseline.

Stage 3: Treat diffuse erythema with IPL

After recovery, IPL is applied across the areas of broad erythema and residual superficial vascularity rather than only to individual vessels.

The reference protocol describes:

Vascular filter: approximately 500 nm
Fluence: approximately 13 J/cm²
Pulse structure: double pulse
Pulse duration: approximately 3.5–4.5 ms
Inter-pulse interval: 10 ms

Contact or surface cooling should be used where supported by the device. The clinic should follow the platform’s validated treatment guidance because IPL fluence and pulse timing are not interchangeable across manufacturers.

Stage 4: Repeat IPL at approximately 40-day intervals

The IPL portion consists of two sessions spaced about 40 days apart in the cited protocol.

The second session should be based on the response to the first, including residual erythema, visible capillary networks, post-treatment inflammation, and any pigmentary response. Repeating identical settings without reassessment is less defensible than adjusting treatment to the patient’s observed response.

How to Select the Treatment Sequence

Treat the deepest or most focal component first

Nd:YAG is placed first because discrete deeper vessels are less effectively addressed by IPL alone. Clearing these vessels before treating the wider field also helps the clinician distinguish persistent focal lesions from background redness.

This sequence is particularly relevant when the face shows both prominent individual telangiectasias and generalized erythema.

Use IPL for the residual vascular background

Once the larger focal vessels have been treated and the skin has recovered, IPL can cover the broader superficial vascular network. This reduces the need to use a focal deep-penetrating treatment across areas that mainly require superficial vascular correction.

Avoid treating every vascular feature with one modality

A single modality may produce partial improvement but leave a clinically important component untreated. The combination works because it is based on vascular depth, vessel caliber, and distribution, not simply on using more energy.

Patient Assessment Before Treatment

Confirm the clinical pattern

Facial redness may reflect rosacea, photodamage, flushing, medication effects, inflammatory disease, or another vascular condition. The clinic should establish whether the presentation is dominated by transient flushing, persistent background erythema, discrete telangiectasia, or a mixture of these findings.

Energy-based treatment should not substitute for appropriate diagnosis or management of an underlying inflammatory or systemic condition.

Assess skin type and pigment risk

Epidermal melanin competes with vascular targets for light absorption. Darker or recently tanned skin generally requires greater caution because the risk of epidermal injury and post-inflammatory hyperpigmentation may be higher.

Assessment should include Fitzpatrick skin type, recent sun exposure, tanning products, history of pigmentary complications, medications, and the presence of active inflammation or infection.

Use conservative testing and documentation

Test spots can help evaluate the patient’s immediate response before treating larger areas. Clinics should document baseline photographs, treatment areas, device settings, cooling method, clinical endpoints, and the patient’s response at follow-up.

This record is essential when adjusting the IPL phase after Nd:YAG treatment.

Understanding the Trade-offs

Higher fluence is not automatically better

Nd:YAG protocols may use relatively high fluences because the wavelength is intended to reach deeper vessels. However, increasing energy without regard to vessel size, skin type, pulse structure, or cooling can cause excessive thermal injury.

The goal is controlled vascular coagulation, not maximal immediate discomfort or surface reaction.

IPL may require multiple treatments

Diffuse erythema represents a broad and often heterogeneous vascular network. Improvement commonly requires more than one IPL session, and some patients may experience recurrent redness or flushing even after visible vessel reduction.

Treatment should therefore be presented as a staged course with reassessment rather than as a guaranteed one-time correction.

Combination treatment increases thermal complexity

Although the modalities are complementary, they are not risk-free when combined in the same overall course. Insufficient recovery between stages, aggressive settings, poor cooling, or treatment of actively irritated skin can increase the risk of prolonged erythema, blistering, scarring, and pigmentary change.

The protocol is device- and patient-dependent

The numerical settings in the reference are not portable across all Nd:YAG and IPL systems. Differences in pulse delivery, spot geometry, filter design, cooling, calibration, and energy reporting can materially change the biological effect.

Only appropriately trained and authorized clinicians should translate these ranges into treatment settings under the applicable local regulations and device instructions.

How to Apply This to Your Clinic

A safe workflow is to classify the vascular findings first, treat the focal deeper component, reassess after recovery, and then address the diffuse superficial component.

If your primary focus is discrete or deeper telangiectasia: Start with a focused 1064 nm Nd:YAG treatment using conservative, device-appropriate parameters, a 5 mm spot where suitable, double-pulse delivery, and effective surface cooling.
If your primary focus is diffuse background erythema or flushing: Use IPL with an appropriate vascular filter and cooling system, generally planning a course of approximately two sessions rather than relying on a single treatment.
If your primary focus is mixed vascular disease: Stage Nd:YAG first, wait approximately 30 days for recovery, then perform IPL sessions approximately 40 days apart with reassessment before each treatment.
If your primary focus is safety in higher-risk skin: Prioritize skin-type assessment, sun avoidance, test spots, conservative endpoints, and documented follow-up over strict adherence to a fixed numerical setting.

A well-structured protocol matches Nd:YAG depth and precision with IPL coverage and superficial vascular control, while clinical judgment determines the settings and timing for each patient.

Summary Table:

Treatment Stage	Modality	Target	Typical Parameters	Interval
1. Focal vessel treatment	Nd:YAG (1064 nm)	Discrete, deeper telangiectasias	Fluence: 75–100 J/cm², Spot: 5 mm, Double pulse, 5–14 ms	Baseline
2. Recovery period	None	Skin healing	—	30 days
3. Diffuse erythema treatment	IPL (vascular filter ~500 nm)	Superficial, diffuse redness	Fluence: ~13 J/cm², Double pulse, 3.5–4.5 ms	After recovery
4. Repeat IPL	IPL	Residual erythema	Based on response	40 days later

Ready to elevate your clinic's vascular treatment offerings?

At BELIS, we provide professional-grade medical aesthetic equipment exclusively for clinics and premium salons. Our portfolio includes advanced Nd:YAG and IPL systems, along with a full spectrum of aesthetic devices. Whether you're targeting telangiectasia, diffuse erythema, or other skin concerns, our technology and support can help you achieve optimal results.

Why partner with BELIS?

Comprehensive Product Range: From laser and IPL to body sculpting and skin rejuvenation.
Clinical Excellence: Evidence-based protocols to maximize treatment efficacy and patient safety.
Training & Support: We ensure your team is confident in operating our devices.
Customizable Solutions: Tailor your equipment choices to your clinic's specific needs.

Enhance your practice with BELIS – Contact us today for a consultation!